Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
First Claim
Patent Images
1. A method of treating a disorder or a disease associated with neutral endopeptidase activity in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a compound of the formula (I);
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a compound of formula I;
or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.
-
Citations
13 Claims
-
1. A method of treating a disorder or a disease associated with neutral endopeptidase activity in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a compound of the formula (I);
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13)
- administering to the subject a therapeutically effective amount of a compound of the formula (I);
-
10. A method of inhibiting neutral endopeptidase activity in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a compound of Formula (I);
- administering to the subject a therapeutically effective amount of a compound of Formula (I);
Specification